Join        Login             Stock Quote

NEWS FLASH: Arena Pharmaceuticals, Inc. (ARNA) Gets FDA Approval For Obesity Drug

 June 27, 2012 01:37 PM

(By Rich Bieglmeier) Arena Pharmaceuticals, Inc. (ARNA) obesity drug, now called Belviq (formerly known as lorcaserin) has been Okayed by an 18-4 vote. It is the first new obesity drug to hit the market in 13 years. The stock has been halted since 12:39 pm Eastern, with a pre-halt trade price of $8.73.

According to the company's press release, "The FDA has recommended that BELVIQ be classified by the U.S. Drug Enforcement Administration (DEA) as a scheduled drug. The DEA will review the FDA's recommendation and determine the final scheduling designation. Once the DEA has provided the final scheduling designation, Eisai will announce when BELVIQ will be available to patients and physicians in the United States."

[Related -Stocks Jump 1 Pct On Strong Jobs Data; AIG Gains]

With 22% of the ARNA's float – stock available for trading – sold short, the approval news is likely to trigger a massive short squeeze. There will be some folks with sore bottoms once the stock resumes trading.

Where the price goes is anybody's guess, but investors are likely to have a new blockbuster biotech to monitor going forward. We know all about the counting your chickens stuff, but congratulations to those who picked up ARNA following our money-flow, Getting Fat on Obesity Stock article on May 15.

UPDATE: Arena has opened for trading. It's been as high as $13.50. Stay tuned as the stock is sure to be volatile. 

iOnTheMarket Premium


6/27/2012 5:22:59 PM
The Only True Cartel by Brandt Hardin
Big Pharma is the REAL drug cartel in North America. Their overmedicating of the American public through obscene advertising leads to nearly 100,000 deaths per year! Prescription drugs are more dangerous than any felony drug substance in the world including heroin, cocaine and even alcohol combined. Read about this issue and what’s killing people at http://dregstudiosart.blogspot.com/2011/07/illustration-friday-800-milligrams.html
Rating: (1) (0)
Post Comment -- Login is required to post message
Alert for new comments:
Your email:
Your Website:

rss feed

Latest Stories

article imageChart Says This Retailer's Comeback Isn't Finished

One of the surprises, at least on the surface, of the market's recent swoon was the outperformance of read on...

article imageETF Performance Review: Major Asset Classes | 19 Dec 2014

It’s all about real estate investment trusts (REITs) these days when it comes to bullish performance among read on...

article imageOil and Global Stock Markets Rebounding Sharply

So far so good on our expectation of a 4 to 5% pullback and then a resumption of the bull read on...

article imageGrading the FOMC

Love its members or loathe them, you have to admire the gradual impact the policy-making committee has had read on...

Popular Articles

Daily Sector Scan
Partner Center

Fundamental data is provided by Zacks Investment Research, and Commentary, news and Press Releases provided by YellowBrix and Quotemedia.
All information provided "as is" for informational purposes only, not intended for trading purposes or advice. iStockAnalyst.com is not an investment adviser and does not provide, endorse or review any information or data contained herein.
The blog articles are opinions by respective blogger. By using this site you are agreeing to terms and conditions posted on respective bloggers' website.
The postings/comments on the site may or may not be from reliable sources. Neither iStockAnalyst nor any of its independent providers is liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein. You are solely responsible for the investment decisions made by you and the consequences resulting therefrom. By accessing the iStockAnalyst.com site, you agree not to redistribute the information found therein.
The sector scan is based on 15-30 minutes delayed data. The Pattern scan is based on EOD data.